ARDS — Aridis Pharmaceuticals Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.01m
- -$0.03m
- $3.09m
U.S. STOCKS ON THE MOVE-Tencent Music, Baudax Bio, Novavax
U.S. STOCKS ON THE MOVE-Titan Pharma, Kellogg, Nordstrom, Embraer SA, Groupon
U.S. STOCKS ON THE MOVE-Energy firms, Aridis Pharma, CytomX, Tesla, General Mills
U.S. STOCKS ON THE MOVE-NIKE, Aldeyra, Micron Technology, Aquestive
Aridis Pharma soars on promising data from anti-viral drug
Brief: Aridis Pharmaceuticals Announces Pan-Coronavirus Monoclonal Antibody Cocktail That Retains Effectiveness Against Omicron,Other COVID-19 Variants
Brief: Aridis Pharma Announces Q3 Loss Per Share Of $1.94
Vaccines, treatments for syncytial virus have blockbuster potential - Cantor
Brief: Aridis Pharmaceuticals Inc Files Shelf Related To Offering Of 884,956 Shares Of Common Stock By Selling Stockholder - SEC Filing
Aridis Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary
Brief: Aridis Pharmaceuticals Announces Second Quarter 2021 Results
Aridis Pharmaceuticals Inc expected to post a loss of 63 cents a share - Earnings Preview
Aridis Pharmaceuticals Inc expected to post a loss of 63 cents a share - Earnings Preview
Brief: Aridis Pharmaceuticals Announces $25 Mln Registered Direct Offering Priced At Premium To Market
U.S. RESEARCH ROUNDUP-Bank of America, Comerica, Wells Fargo & Co
Brief: Aridis Announces Exclusive License Of Suvratoxumab From AstraZeneca
Aridis Pharma gains as drug cocktail neutralizes Delta COVID-19 variant
Brief: Aridis Pharmaceuticals Covid Mab Ar-712 Neutralizes Sars-Cov-2 Delta Variant
Brief: Aridis Pharmaceuticals Inc Says Michael A. Nazak Notified Co Of His Decision To Resign As CFO